Clinical Trials Directory

Trials / Unknown

UnknownNCT05305326

Telocytes in Placental Tissues of Patients With Gestational and Pre-gestational Diabetes

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Examining the expression of telocytes in the placental tissues and umbilical cord of patients with gestational or pregestational diabetes during pregnancy compared to control.

Detailed description

this is an observational study, patients with gestational or pre-gestational diabetes undergoing elective (pre-labour) Cesarean section will be asked to participate in the study. Samples of placenta and umbilical cord will be taken postpartum and will be fixed and examined using immunohistochemistry to measure abundance of telocytes in these tissues. another group of patients with non complicated pregnancies will be asked to join as a control. As the topic was never studied before, a pilot phase of 10 patients per group will be done followed by sample size collection based on SD of number of telocytes in each group. Diabetes patients will divided in 3 subgroups; Gestational diabetes and pre-gestational diabetes type 1 or 2. Each group will be further subdivided according to HBA1C level collected at the time of delivery into controlled or non controlled.

Conditions

Timeline

Start date
2021-12-01
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2022-03-31
Last updated
2022-03-31

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05305326. Inclusion in this directory is not an endorsement.